GlassScriptPhysician profile
James V Alsop
NPI 1942683263
$506.11
in general payments reported to CMS, 2019-2025
10 companies · $37.79 in 2025
The $37.79 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.04 · 2021: $46.38 · 2022: $70.73 · 2023: $117 · 2024: $145 · 2025: $37.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $172.19 | 2021-2024 | |
| Pfizer INC. | $115.79 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $61.52 | 2022-2024 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $43.52 | 2019-2024 | Zerbaxa, Recarbrio |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.11 | 2021 | |
| Inari Medical, INC. | $25.06 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.40 | 2019 | |
| Chiesi USA, INC. | $15.65 | 2025 | Cleviprex |
| Allergan, INC. | $13.94 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Alsop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.